Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer

The use of immune checkpoint inhibitors (ICIs) continues to transform the therapeutic landscape of non-small cell lung cancer (NSCLC), with these drugs now being evaluated at every stage of the disease. In contrast to these advances, little progress has been made with respect to reliable predictive...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcos Rubio, Alvaro, Everaert, Celine, Van Damme, Eufra, De Preter, Katleen, Vermaelen, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401220/
https://www.ncbi.nlm.nih.gov/pubmed/37536935
http://dx.doi.org/10.1136/jitc-2023-007023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401220/
https://www.ncbi.nlm.nih.gov/pubmed/37536935
http://dx.doi.org/10.1136/jitc-2023-007023

Ejemplares similares